Institutional investors control 36.13% of the outstanding shares in OREX. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended March 2017, these large investors purchased a net $702.3 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CUTLER GROUP LP Bought 2.6 Thousand shares of Orexigen Therapeutics Inc